National Institute on Drug Abuse: Notice of Closed Meetings, 15015-15016 [2015-06349]
Download as PDF
<![CDATA[
Federal Register / Vol. 80, No. 54 / Friday, March 20, 2015 / Notices
05, 7500 Security Boulevard, Baltimore,
Maryland 21244–1850.
To obtain copies of a supporting
statement and any related forms for the
proposed collection(s) summarized in
this notice, you may make your request
using one of following:
1. Access CMS’ Web site address at
https://www.cms.hhs.gov/
PaperworkReductionActof1995.
2. Email your request, including your
address, phone number, OMB number,
and CMS document identifier, to
Paperwork@cms.hhs.gov.
3. Call the Reports Clearance Office at
(410) 786–1326.
FOR FURTHER INFORMATION CONTACT:
Reports Clearance Office at (410) 786–
1326.
SUPPLEMENTARY INFORMATION:
Contents
This notice sets out a summary of the
use and burden associated with the
following information collections. More
detailed information can be found in
each collection’s supporting statement
and associated materials (see
ADDRESSES).
CMS–10550 Hospital National
Provider Survey
mstockstill on DSK4VPTVN1PROD with NOTICES
CMS–10551 Nursing Home National
Provider Survey
Under the PRA (44 U.S.C. 3501–
3520), federal agencies must obtain
approval from the Office of Management
and Budget (OMB) for each collection of
information they conduct or sponsor.
The term ‘‘collection of information’’ is
defined in 44 U.S.C. 3502(3) and 5 CFR
1320.3(c) and includes agency requests
or requirements that members of the
public submit reports, keep records, or
provide information to a third party.
Section 3506(c)(2)(A) of the PRA
requires federal agencies to publish a
60-day notice in the Federal Register
concerning each proposed collection of
information, including each proposed
extension or reinstatement of an existing
collection of information, before
submitting the collection to OMB for
approval. To comply with this
requirement, CMS is publishing this
notice.
Information Collection
1. Type of Information Collection
Request: New collection (Request for a
new OMB control number); Title of
Information Collection: Hospital
National Provider Survey; Use: Section
3104 of the Patient and Protection and
Affordable Care Act (ACA) requires that
the Secretary of the Department of
Health and Human Services (HHS)
conduct an assessment of the quality
VerDate Sep<11>2014
20:14 Mar 19, 2015
Jkt 235001
and efficiency impact of the use of
endorsed measures in specific Medicare
quality reporting and incentive
programs. The ACA further specifies
that the initial assessment must occur
no later than March 1, 2012, and once
every 3 years thereafter. This planned
data collection activity was developed
and tested as part of the 2015 Impact
Report and data collection will be
conducted for reporting in the 2018
Impact Report.
There are two modes of data
collection with hospital quality leaders:
(1) A semi-structured qualitative
interview and (2) a standardized survey.
The data from the qualitative interviews
and standardized surveys will be
analyzed to provide us with information
on the quality and efficiency impact of
measures that we use to assess care in
the hospital inpatient and outpatient
settings. The surveys seek to understand
whether the use of performance
measures has led to changes in provider
behavior, and where undesired effects
are occurring as a result of
implementing quality and efficiency
measures. The survey will also help
identify characteristics associated with
high performance, which if understood,
could be used to leverage improvements
in care among lower performing
hospitals. The focus of the survey is to
assess the impacts of the measures that
we use in the context of public reporting
(pay-for-reporting) and value-based
purchasing programs. Form Number:
CMS–10550 (OMB control number:
0938–NEW); Frequency: Occasionally;
Affected Public: Private Sector (Business
or other for-profit and Not-for-profit
institutions); Number of Respondents:
940; Total Annual Responses: 940; Total
Annual Hours: 639. (For policy
questions regarding this collection
contact Noni Bodkin at 410–786–7837.)
2. Type of Information Collection
Request: New collection (Request for a
new OMB control number); Title of
Information Collection: Nursing Home
National Provider Survey; Use: Section
3104 of the Patient and Protection and
Affordable Care Act (ACA) requires that
the Secretary of the Department of
Health and Human Services (HHS)
conduct an assessment of the quality
and efficiency impact of the use of
endorsed measures in specific Medicare
quality reporting and incentive
programs. The ACA further specifies
that the initial assessment must occur
no later than March 1, 2012, and once
every 3 years thereafter. This planned
data collection activity was developed
and tested as part of the 2015 Impact
Report and data collection will be
conducted for reporting in the 2018
Impact Report.
PO 00000
Frm 00111
Fmt 4703
Sfmt 4703
15015
There are two modes of data
collection with nursing home quality
leaders: (1) A semi-structured
qualitative interview and (2) a
standardized survey. The data from the
qualitative interviews and standardized
surveys will be analyzed to provide us
with information on the quality and
efficiency impact of measures that we
use to assess care in nursing homes
delivering skilled nursing care. The
surveys seek to understand whether the
use of performance measures has led to
changes in provider behavior (both at
the nursing home-level and at the
frontline of care), and whether
undesired effects are occurring as a
result of implementing quality and
efficiency measures. The survey will
also help identify characteristics
associated with high performance,
which if understood, could be used to
leverage improvements in care among
lower performing nursing homes. The
focus of the survey is to assess the
impacts of the measures that we use in
the context of public reporting (pay-forreporting) and quality improvement.
Form Number: CMS–10551 (OMB
control number: 0938–NEW);
Frequency: Occasionally; Affected
Public: Private Sector (Business or other
for-profit and Not-for-profit
institutions); Number of Respondents:
940; Total Annual Responses: 940; Total
Annual Hours: 639. (For policy
questions regarding this collection
contact Noni Bodkin at 410–786–7837.)
Dated: March 17, 2015.
William N. Parham, III,
Director, Paperwork Reduction Staff, Office
of Strategic Operations and Regulatory
Affairs.
[FR Doc. 2015–06408 Filed 3–19–15; 8:45 am]
BILLING CODE 4120–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute on Drug Abuse:
Notice of Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable materials,
and personal information concerning
individuals associated with the grant
E:\FR\FM\20MRN1.SGM
20MRN1
15016
Federal Register / Vol. 80, No. 54 / Friday, March 20, 2015 / Notices
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute on
Drug Abuse Special Emphasis Panel; Review
of Project Grant Applications for Multi-site
Clinical Trials.
Date: March 31, 2015.
Time: 8 a.m. to 8:30 a.m.
Agenda: To review and evaluate grant
applications.
Place: Hilton Garden Inn Bethesda, 7301
Waverly Street, Bethesda, MD 20814.
Contact Person: Susan O. McGuire, Ph.D.,
Scientific Review Officer, Office of
Extramural Affairs, National Institute on
Drug Abuse, National Institutes of Health,
DHHS, 6001 Executive Blvd., Room 4245,
Rockville, MD 20852, 301–435–1426,
mcguireso@mail.nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
Name of Committee: National Institute on
Drug Abuse Special Emphasis Panel; Cohort
Studies of HIV/AIDS and Substance Use
(U01).
Date: April 2, 2015.
Time: 8:30 a.m. to 4 p.m.
Agenda: To review and evaluate
cooperative agreement applications.
Place: Hilton Garden Inn Bethesda, 7301
Waverly Street, Bethesda, MD 20814.
Contact Person: Susan O. McGuire, Ph.D.,
Scientific Review Officer, Office of
Extramural Affairs, National Institute on
Drug Abuse, National Institutes of Health,
DHHS, 6001 Executive Blvd., Room 4245,
Rockville, MD 20852, 301–435–1426,
mcguireso@mail.nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
Name of Committee: National Institute on
Drug Abuse Special Emphasis Panel; CuttingEdge Basic Research Awards (CEBRA) (R21).
Date: April 2, 2015.
Time: 12 p.m. to 3 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Neuroscience Center, 6001 Executive
Boulevard, Rockville, MD 20852, (Virtual
Meeting).
Contact Person: Jagadeesh S. Rao, Ph.D.,
Scientific Review Officer, Office of
Extramural Affairs, National Institute on
Drug Abuse, National Institutes of Health,
DHHS, 6001 Executive Boulevard, Room
4234, MSC 9550, Bethesda, MD 20892, 301–
443–9511, jrao@nida.nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
(Catalogue of Federal Domestic Assistance
Program Nos.: 93.279, Drug Abuse and
Addiction Research Programs, National
Institutes of Health, HHS)
Dated: March 13, 2015.
Michelle Trout,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2015–06349 Filed 3–19–15; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Administration for Children and
Families
Proposed Information Collection
Activity; Comment Request
Title: Multi-Site Evaluation of Project
LAUNCH.
(OMB No.: 0970–0373)
Description: The Administration for
Children and Families (ACF), U.S.
Department of Health and Human
Services, is planning to collect data for
the multi-site evaluation (MSE) of
Project LAUNCH (Linking Actions for
Unmet Needs in Children’s Health).
Project LAUNCH is intended to promote
healthy development and wellness in
children from birth to eight years of age.
Project LAUNCH grantees are funded by
the Substance Abuse and Mental Health
Services Administration (SAMHSA) to
improve coordination among childserving systems, enhance systems
coordination, integrate child behavioral
health services with other health
services, and implement evidence-based
programs to address children’s healthy
development.
The Project LAUNCH MSE seeks to
determine the impact of the combined
LAUNCH services and strategies on
child, family, and systems level
outcomes. Data for the MSE will be
collected through several mechanisms.
First, all LAUNCH grantees will submit
semi-annual reports through a webbased data entry system. Second, Project
LAUNCH grantees will be
systematically sampled to include 10
non-tribal and 5 tribal sites, and
matched comparison communities (10
non-tribal and 5 tribal) will be recruited
to participate in data collection efforts.
Within each site, 2 elementary schools
and 4 early childhood education (ECE)
centers will be selected as data
collection sites. Data collected from this
sample of LAUNCH and comparison
communities will include:
• Surveys of parents of a sample of
young children (birth through age eight).
Topics include child health, social
emotional health, school readiness,
parent-child relationships, parent
depression, home environment, and
parental social support.
• Surveys of a sample of kindergarten
teachers. The survey will assess
kindergarten students’ school readiness
in the areas of physical health and wellbeing; social competence; emotional
maturity; language and cognitive
development; and communication
skills.
• Surveys of elementary school and
ECE administrators. The survey will
assess child suspension and expulsion.
In addition, key informant interviews
will be conducted with local and state
early childhood leaders to gather
contextual information about systemslevel activities and change.
Respondents: All Project LAUNCH
grantees for the web-based data
collection; a systematic sample of
parents, teachers, elementary school and
ECE administrators in both LAUNCH
and comparison communities; and key
informants at the local and state levels
in both LAUNCH and comparison
communities.
ANNUAL BURDEN ESTIMATES
mstockstill on DSK4VPTVN1PROD with NOTICES
Direct Service Activities web-based data collection ............
Systems Activities and Outcomes web-based data collection ....................................................................................
Parent Survey ......................................................................
Teacher Survey ....................................................................
School Suspension and Expulsion Survey ..........................
Systems Change Interview ..................................................
VerDate Sep<11>2014
20:14 Mar 19, 2015
Jkt 235001
Annual No. of
respondents
Number of responses per
respondent
Average burden hours per
response
Annual burden
hours
96
32
6
8.5
1632
96
8100
720
540
315
32
2700
240
180
105
3
3
3
3
3
8
0.5
10
1
1
768
4050
7200
540
315
Total No. of
respondents
Instrument
PO 00000
Frm 00112
Fmt 4703
Sfmt 4703
E:\FR\FM\20MRN1.SGM
20MRN1
]]>Agencies
[Federal Register Volume 80, Number 54 (Friday, March 20, 2015)]
[Notices]
[Pages 15015-15016]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2015-06349]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute on Drug Abuse: Notice of Closed Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is hereby given of the following
meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable materials, and personal information concerning individuals
associated with the grant
[[Page 15016]]
applications, the disclosure of which would constitute a clearly
unwarranted invasion of personal privacy.
Name of Committee: National Institute on Drug Abuse Special
Emphasis Panel; Review of Project Grant Applications for Multi-site
Clinical Trials.
Date: March 31, 2015.
Time: 8 a.m. to 8:30 a.m.
Agenda: To review and evaluate grant applications.
Place: Hilton Garden Inn Bethesda, 7301 Waverly Street,
Bethesda, MD 20814.
Contact Person: Susan O. McGuire, Ph.D., Scientific Review
Officer, Office of Extramural Affairs, National Institute on Drug
Abuse, National Institutes of Health, DHHS, 6001 Executive Blvd.,
Room 4245, Rockville, MD 20852, 301-435-1426,
mcguireso@mail.nih.gov.
This notice is being published less than 15 days prior to the
meeting due to the timing limitations imposed by the review and
funding cycle.
Name of Committee: National Institute on Drug Abuse Special
Emphasis Panel; Cohort Studies of HIV/AIDS and Substance Use (U01).
Date: April 2, 2015.
Time: 8:30 a.m. to 4 p.m.
Agenda: To review and evaluate cooperative agreement
applications.
Place: Hilton Garden Inn Bethesda, 7301 Waverly Street,
Bethesda, MD 20814.
Contact Person: Susan O. McGuire, Ph.D., Scientific Review
Officer, Office of Extramural Affairs, National Institute on Drug
Abuse, National Institutes of Health, DHHS, 6001 Executive Blvd.,
Room 4245, Rockville, MD 20852, 301-435-1426,
mcguireso@mail.nih.gov.
This notice is being published less than 15 days prior to the
meeting due to the timing limitations imposed by the review and
funding cycle.
Name of Committee: National Institute on Drug Abuse Special
Emphasis Panel; Cutting-Edge Basic Research Awards (CEBRA) (R21).
Date: April 2, 2015.
Time: 12 p.m. to 3 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Neuroscience Center, 6001
Executive Boulevard, Rockville, MD 20852, (Virtual Meeting).
Contact Person: Jagadeesh S. Rao, Ph.D., Scientific Review
Officer, Office of Extramural Affairs, National Institute on Drug
Abuse, National Institutes of Health, DHHS, 6001 Executive
Boulevard, Room 4234, MSC 9550, Bethesda, MD 20892, 301-443-9511,
jrao@nida.nih.gov.
This notice is being published less than 15 days prior to the
meeting due to the timing limitations imposed by the review and
funding cycle.
(Catalogue of Federal Domestic Assistance Program Nos.: 93.279, Drug
Abuse and Addiction Research Programs, National Institutes of
Health, HHS)
Dated: March 13, 2015.
Michelle Trout,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2015-06349 Filed 3-19-15; 8:45 am]
BILLING CODE 4140-01-P
